Bon Natural Life Limited

• Cayman Islands
• Bon Natural Life Limited
• Capital-Goods

BON

Xi’an App-Chem Bio (Tech) Co., Ltd (“Xi’an App-Chem Bio (Tech)”) was established in 2006. The company is located in the state-level Xi’an Hi-tech Development Zone. “Quality, innovation, value” is the core concept of Xi’an App-Chem. Xi’an App-Chem focuses on the field of natural products, and our mission is to create value by providing high-quality innovative products and services for customers. Xi’an App-Chem operates through nine subsidiaries:
 
      ?     Shaanxi App-Chem Health Industry Co., Ltd. (App-Chem Health)
             
      ?     Xi’an Yanhuang TCM Medical Research and Development Co., Ltd. (“Xi’an YH”)
             
      ?     Shaanxi App-Chem Ag-tech Co., Ltd. (“App-Chem Ag-tech”)
             
      ?     Xi’an Dietary Therapy Health Management Co., Ltd. (“Xi’an DT”)
             
      ?     Tongchuan Dietary Therapy Health Technology Co., Ltd. (“Tongchuan DT)
             
      ?     Balikun Tianmei Bio (Tech) Co., Ltd. (“Balikun”)
             
      ?     App-Chem Bio (Tech) (Guangzhou) Co., Ltd. (“App-Chem Guangzhou”)
             
      ?     Gansu Baimeikang Bioengineering Co., Ltd.; (“Gansu BMK”) and
             
      ?     Tianjin Yonghexiang Bio (Tech) Co., Ltd. (“ Tianjin YHX”)

We were co-founded by a team of top-level executives from China’s domestic natural products industry, together with experts returned from overseas. For the past 10 years, we have focused on the core needs of the natural products industry, emphasizing technological innovation and supply chain integration. We are devoted to providing a stable supply of high-quality products and services at competitive prices for the functional food, personal care, cosmetic and pharmaceutical industries. “Nourish life with natural essence” is our business concept, and “Becoming an innovative leader of natural functional ingredients and an integrated supplier for the health industry” is our goal. We have formed four technology platforms as follows:

      1.     Commercial scale natural ingredient extraction and separation platform built with technologies such as continuous dynamic extraction and molecular distillation and membrane separation (“Technical Platform 1”);
             
      2.     Natural extraction safety improvement and assurance platform designed with technology to remove heavy metal, pesticide, and other harmful residues (“Technical Platform 2”);
             
      3.     Platform of bioactive ingredient of natural extract enhancement built with technology seeking to increase human absorption rate of naturally extracted ingredients by increasing their water solubility and utilizing drug delivery system (“Technical Platform 3”); and
             
      4.     Natural extract formulation technology platform based on steady state technology with focus on formulation of natural anti-oxidant and functional oligosaccharide to achieve stable output, high purity and absorption rate (“Technical Platform 4”). 
 

Offering Team

Pre-IPO Investors

Deal Highlights

less

More

Deal Tracker

Stock Price